Table 4. The diagnostic efficacy of each BDG detection kit (N = 164).
| Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | LR+ | LR- | |
|---|---|---|---|---|---|---|
| ES | 90.9 (10/11) | 91.5 (140/153) | 43.5 (10/23) | 99.3 (140/141) | 10.7 | 0.1 |
| FA | 63.6 (7/11) | 91.5 (140/153) | 35.0 (7/20) | 97.2 (140/144) | 7.5 | 0.4 |
| MKII | 100 (11/11) | 90.8 (139/153) | 44.0 (11/25) | 100 (139/139) | 10.9 | 0.0 |
| Wako | 100 (11/11) | 96.1 (147/153) | 64.7 (11/17) | 100 (147/147) | 25.5 | 0.0 |
| Wako-Eu | 100 (11/11) | 96.1 (147/153) | 64.7 (11/17) | 100 (147/147) | 25.5 | 0.0 |
BGD, β-D-glucan; PPV, Positive predictive value; NPV, Negative predictive value; LR+, Positive likelihood ratio; LR-, Negative likelihood ratio; ES: Fungitec G test ES “Nissui”; FA, Fungitell β-D-glucan assay kit; MKII, Fungitec G test MKII “Nissui”; Wako, β-Glucan test Wako; Wako-Eu, European version of β-Glucan test Wako.